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The action of substrate analogs containing the tetrazolyl group instead of the C-terminal carboxy group 
on the peptidase activity of carboxypeptidase A is studied. The analogs compete with the substrate for the 
secondary binding site thus showing activation phenomena. 
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1. INTRODUCTION 
The 5substituted tetrazolyl group has some 
structural features in common with the carboxy 
group [I]. The acidity of the tetrazole nucleus cor- 
responds with that of a carboxy group in peptides 
[2] and tetrazolate and carboxylate anions both 
have planar structures. To study the role of free 
carboxy groups in biologically active systems 
several tetrazole analogs of amino acids and 
biologically active peptides were synthesized and 
structure-function relationships in enzymatic [3-51 
and hormonal [6] systems were investigated. 
For these studies carboxypeptidase A (EC 
3.4.17.1) should be an interesting example, since it 
needs a free carboxylate group in the C-terminal 
position of a peptide substrate which binds by two 
hydrogen bonds to Arg-145 of the active site of the 
enzyme [7]. 
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We have found that Z-Gly-Phe-T (I), the 
tetrazole analog of the typical substrate of carbox- 
ypeptidase A (Z-Gly-Phe-OH), is not hydrolyzed 
by the enzyme but acts as a modifier of the enzyme 
catalysis. 
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Here, the mode of action of derivatives of tetrazole 
analogs of amino acids was tested for their capaci- 
ty to modify the kinetics of the hydrolysis of Z- 
Gly-Phe-OH by carboxypeptidase A. Z-Gly-Phe- 
OH itself and Z-Gly-OH are known to cause 
stimulation of the peptidase activity of the enzyme 
[8,9]. The mechanism of this acceleration of car- 
boxypeptidase A activity has been described [7, lo]. 
2. MATERIALS AND METHODS 
Z-Gly-OH, Z-Gly-Phe-OH [ 1 l] and Z-Gly-T 
[ 121 were prepared in our laboratories. Z-Gly-Phe- 
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T was synthesized from Z-Gly-ONp and L-H-Phe- 
T according to [13]: m.p. 140-142°C; [cy]: = 
-21.8” (c = 1, MeOH). TLC, Rf 0.34 (CHC13: 
EtOH, 3 : 1, v/v); Rf 0.47 (CHC4 : MeOH : AcOH, 
18 : 1 : 1, v/v) on silica gel 60 plates (Merck). For 
CrsHzoN,jO3, found: C 60.1070, H 5.1070, N 21.9%; 
calculated: C 60.0070, H 5.3%, N 22.1%. 
Carboxypeptidase A (bovine pancreas) was pur- 
chased from Serva (Heidelberg). Enzyme stock 
solutions in 2.36 mol/l LiCl and 1 mmol/l Na- 
veronal-HCI, pH 7.6, were prepared according to 
[lo]. Kinetic measurements were made at 25”C, 
pH 7.6, 0.6 mol/l LiCl, 22.5 mmol/l Na-veronal- 
HCl as described in [lo]. The liberated 
phenylalanine from substrate hydrolysis was deter- 
mined by the calorimetric ninhydrin procedure of 
[ 141. All experiments were run in duplicate. Due to 
substrate activation the Lineweaver-Burk plot was 
not a straight line (curves A and B in fig.2). For the 
evaluation of the kinetic parameters a computer 
program [15] was employed. 
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Fig.1. Acceleration of carboxypeptidase A activity at 
constant substrate concentration (Z-Gly-Phe-OH, 
1.25 mmol/l). Activators (A): (0) Z-Gly-OH, (A) Z- 
Gly-T, ( n ) Z-Gly-Phe-T, v and vg represent velocities in 
the presence and absence of activator, respectively. 
3. RESULTS AND DISCUSSION 
In several experiments (prolonged incubation, 
high enzyme concentrations) it was shown that Z- 
Gly-Phe-T was not split by carboxypeptidase A. 
The substrate analog remained unchanged as 
judged by chromatographic methods. To study the 
potential inhibitory effect of the substrate analog 
we added this compound to incubation mixtures of 
carboxypeptidase A and Z-Gly-Phe-OH. Surpris- 
ingly we observed an activation phenomenon. 
a secondary binding 
(fig.2). 
The influence 
(30 mmol/l) of the 
site (Arg-127, Arg-71, [7]) 
of high concentrations 
analog I on the kinetic 
The effects of different concentrations of Z-Gly- 
OH, Z-Gly-T and Z-Gly-Phe-T on the hydrolysis 
of Z-Gly-Phe-OH are shown in fig. 1 and agree well 
with similar experiments by other authors [lo] us- 
ing Z-amino acids and -peptides as modifiers 
which were not split by the enzyme. 
Kinetic measurements of the activation 
phenomenon revealed that the tetrazole analogs 
compete with the activating substrate molecule in 
parameters of the enzymatic hydrolysis of Z-Gly- 
Phe-OH results in a decrease in K,,, by a factor of 
2.6 (table 1) indicating the formation of an 
enzyme-modifier complex which has a higher af- 
finity for the substrate than the free enzyme. The 
catalytic capacity of this complex (kc& is increased 
nearly 2-fold as compared with the free enzyme. 
Besides the high capacity of the tetrazolate ion 
to form hydrogen bonds [16] our experiments 
demonstrate that the substrate analog cannot bind 
to Arg-145. This may be due to the different 
shapes of the tetrazolate and carboxylate ions 
respectively in hydrogen bonding (scheme 1). 
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Fig.2. Acceleration of carboxypeptidase A activity at constant activator concentration. Lineweaver-Burk plot for the 
hydrolysis of Z-Gly-Phe-OH in the absence (0) and presence of Z-Gly-Phe-T at 6 mmol/l (A) and 30 mmol/l ( n ). 
Table 1 
Kinetic data for the hydrolysis of Z-Gly-Phe-OH (l-20 mmol/l) by carboxypeptidase A 
at pH 7.6 in the presence of high concentrations of Z-Gly-Phe-T 
Km c K,,/K, kot/k,,t, C/C, 
(mm01 9 1-l) 3, (l*mol-‘as-‘) 
0.47 f 0.092 86.0 f 2.52 183000 2.6 1.9 5.0 
Km0 (1.21 f 0.215 mmol-l-I), kc,,, (44.2 + 2.95 s-‘) and C, = kc&K,, 
(36530 1. mol-’ * s-l) represent data (mean values f SD) in the absence of modifier at low 
concentrations of Z-Gly-Phe-OH (l-4 mmol/l, no substrate activation observed, see 
curve A in fig.2). l/K,, kcat and C represent data in the presence of Z-Gly-Phe-T 
(30 mmol/l). The difference of the kinetic parameters is significant within a confidence 
interval of 2.4 x SD (98.36%) 
The strong chelating properties of the tetrazole 
groups [17] seem not to interfere with the Zn atom 
of the active center of carboxypeptidase A for even 
at high concentrations of the tetrazole analogs no 
inhibition of the peptidase activity was observed. 
The results can be understood best if it is as- 
sumed that the tetrazole analogs bind to the secon- 
dary binding site [7] thus forming an enzyme- 
modifier complex which has higher activity than 
the free enzyme (table 1). 
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